Patents by Inventor Camilla Bacci

Camilla Bacci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE UNITS AND REGIMEN, USES, METHODS OR FORMULATIONS OF COMPOSITIONS COMPRISING A RECOMBINANT PROTEIN COMPRISING INTERLEUKIN-12 AND AN ANTIBODY BINDING THE EXTRA-DOMAIN B OF FIBRONECTIN
    Publication number: 20230312726
    Abstract: The present invention relates to a dosage unit or regimen, recombinant protein for use, method or formulation of a recombinant protein comprising interleukin-12 (IL-12) and an antibody binding the extra-domain B (ED-B) of fibronectin, or a target binding fragment or derivative thereof.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 5, 2023
    Applicant: PHILOGEN S.P.A.
    Inventors: Camilla BACCI, Theresa HEMMERLE
  • ANTIBODY COMPOSITIONS
    Publication number: 20230165960
    Abstract: This invention relates to stable formulations that can be prepared to high concentration of active agent using low amounts of detergents and to methods for producing such formulations. In particular, this invention relates to formulations containing the L19-TNF? immunocytokine.
    Type: Application
    Filed: May 25, 2022
    Publication date: June 1, 2023
    Applicant: Philogen S.p.A.
    Inventors: Giovanni Neri, Camilla Bacci
  • Antibody compositions
    Patent number: 11351257
    Abstract: This invention relates to stable formulations that can be prepared to high concentration of active agent using low amounts of detergents and to methods for producing such formulations. In particular, this invention relates to formulations containing the L19-TNF? immunocytokine.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: June 7, 2022
    Assignee: PHILOGEN S.P.A.
    Inventors: Giovanni Neri, Camilla Bacci
  • Antibody Compositions
    Publication number: 20210093720
    Abstract: This invention relates to stable formulations that can be prepared to high concentration of active agent using low amounts of detergents and to methods for producing such formulations. In particular, this invention relates to formulations containing the L19-TNF? immunocytokine.
    Type: Application
    Filed: June 14, 2017
    Publication date: April 1, 2021
    Inventors: Giovanni Neri, Camilla Bacci